Patent | Date |
---|
Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4- -amine for inhibiting toll-like receptor activity Grant 10,947,245 - Ding , et al. March 16, 2 | 2021-03-16 |
Tlr7 Agonist Maleate Salt, Crystalline Forms C, D And E Thereof, Preparation Methods And Uses Of Maleate Salt And Crystalline Forms App 20200368241 - DING; Zhaozhong ;   et al. | 2020-11-26 |
TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms Grant 10,780,091 - Ding , et al. Sept | 2020-09-22 |
Method For Preparing Pyrrolo[3,2,-d]pyrimidine Compound, And Intermediates Thereof App 20200239484 - DING; Zhaozhong ;   et al. | 2020-07-30 |
TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses Grant 10,683,296 - Ding , et al. | 2020-06-16 |
7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist Grant 10,676,478 - Ding , et al. | 2020-06-09 |
Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof Grant 10,654,856 - Ding , et al. | 2020-05-19 |
Pyrrolopyrimidine compounds used as TLR7 agonist Grant 10,555,949 - Ding , et al. Feb | 2020-02-11 |
Tlr7 Agonist Crystalline Form A, Preparation Method And Use Thereof App 20200039988 - DING; Zhaozhong ;   et al. | 2020-02-06 |
Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof Grant 10,442,811 - Ding , et al. Oc | 2019-10-15 |
Tlr7 Agonist Maleate Salt, Crystalline Forms C, D And E Thereof, Preparation Methods And Uses Of Maleate Salt And Crystalline Forms App 20190070179 - DING; Zhaozhong ;   et al. | 2019-03-07 |
Tlr7 Agonist Crystalline Form A, Preparation Method And Use Thereof App 20190040071 - DING; Zhaozhong ;   et al. | 2019-02-07 |
Method For Preparing Pyrrolo[3,2-d]pyrimidine Compound, And Intermediates Thereof App 20190040072 - DING; Zhaozhong ;   et al. | 2019-02-07 |
Tlr7 Agonist Trifluoroacetate Salt And Crystalline Form B Thereof, Preparation Methods And Uses App 20190031666 - DING; Zhaozhong ;   et al. | 2019-01-31 |
7-(thiazol-5-yl) Pyrrolopyrimidine Compound As Tlr7 Agonist App 20180370976 - DING; Zhaozhong ;   et al. | 2018-12-27 |
Pyrrolopyrimidine Compounds Used As Tlr7 Agonist App 20180303832 - DING; Zhaozhong ;   et al. | 2018-10-25 |
Preparation method for benzoxazoleoxazine ketone compound and intermediate and crystal form thereof Grant 10,106,557 - Chen , et al. October 23, 2 | 2018-10-23 |
Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide Grant 10,053,477 - Ding , et al. August 21, 2 | 2018-08-21 |
Pyrrolopyrimidine compounds used as TLR7 agonist Grant 9,962,388 - Ding , et al. May 8, 2 | 2018-05-08 |
Hydrazine compound as blood coagulation factor Xa inhibitor Grant 9,938,272 - Ding , et al. April 10, 2 | 2018-04-10 |
Pyridine derivatives and anti-mycobacterial use thereof Grant 9,878,982 - Ding , et al. January 30, 2 | 2018-01-30 |
Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors Grant 9,856,262 - Wang , et al. January 2, 2 | 2018-01-02 |
Pyrrolopyrimidine Compounds Used As Tlr7 Agonist App 20170273983 - DING; Zhaozhong ;   et al. | 2017-09-28 |
Preparation Method For Benzoxazoleoxazine Ketone Compound And Intermediate And Crystal Form Thereof App 20170275299 - CHEN; Shuhui ;   et al. | 2017-09-28 |
Pyridine Derivatives And Anti-mycobacterial Use Thereof App 20170174628 - DING; Zhaozhong ;   et al. | 2017-06-22 |
HYDRAZINE COMPOUND AS BLOOD COAGULATION FACTOR Xa INHIBITOR App 20170152259 - DING; Zhaozhong ;   et al. | 2017-06-01 |
Spirocyclic Aryl Phosphorus Oxide And Aryl Phosphorus Sulfide App 20170129909 - DING; Zhaozhong ;   et al. | 2017-05-11 |
ANALOGUES OF 4H-PYRAZOLO[1,5-a] BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS App 20170029430 - WANG; Xuehai ;   et al. | 2017-02-02 |